部分X染色体单体患者使用自身卵母细胞进行非整倍体植入前遗传学检测:该适应证是否合适?
回顾性观察性多中心研究描述嵌合型特纳综合征(MTS)患者使用自身卵母细胞行PGT-A的结局,并比较PGT-A与卵母细胞捐赠(OD)及X染色体缺失类型的影响;结论认为OD是特纳综合征女性最佳生殖选择,但PGT-A对MTS患者使用自身卵母细胞是有效治疗选择,不应直接推荐OD。
要点
- MTS患者每胚胎移植活产率PGT-A为22.5%,OD为37.7%。
- MTS患者每患者活产率PGT-A为12.5%,OD为51.1%,差异显著。
- 部分MTS与纯特纳综合征每患者活产率分别为51.1%与15%。
核心结论
- 卵母细胞捐赠是伴或不伴嵌合的特纳综合征女性的最佳生殖选择。
- 然而,PGT-A是MTS患者使用自身卵母细胞的有效治疗选择,不应直接推荐OD。
研究设计与样本
- 回顾性观察性多中心研究,设置于大学附属私立体外受精中心。
- 56例MTS患者进行了65个卵巢刺激周期用于PGT-A(荧光原位杂交/芯片-下一代测序)。
- 研究纳入90例MTS女性和20例纯特纳综合征(PTS)女性,分别进行了140个和25个卵母细胞捐赠(OD)周期。
主要发现
- MTS患者每胚胎移植活产率(LBR)OD为37.7%(95%CI 29.3-46.1),PGT-A为22.5%(95%CI 7.8-38.2),前者趋于更高;累积活产率(CLBR)分别为77.6%与43.3%。
- MTS患者每患者LBR比较PGT-A与OD,分别为12.5%(95%CI 3.9-21.1)与51.1%(95%CI 40.7-61.4),差异显著。
- 聚焦X染色体,部分MTS与PTS每胚胎移植CLBR分别为77.6%与29.2%,差异显著;每患者LBR分别为51.1%(95%CI 40.7-61.4)与15%(95%CI 0.0-30.1)。
临床怎么用
- 作者认为,卵母细胞捐赠是伴或不伴嵌合的特纳综合征女性的最佳生殖选择。
- 作者认为,PGT-A是MTS患者使用自身卵母细胞的有效治疗选择,不应直接推荐OD。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe the outcome of preimplantation genetic testing (PGT-A) using their own oocytes in patients with mosaic Turner Syndrome (MTS). The impact of the assisted reproduction technique (ART) performed (PGT-A or oocyte donation) and the type of absence of the X chromosome (total or partial) were considered. DESIGN: Retrospective observational multicenter study. SETTING: University-affiliated private in vitro fertilization center. PATIENT(S): Fifty-six patients with MTS with whom 65 ovarian stimulation cycles for PGT-A (fluorescence in situ hybridization/arrays-next generation sequencing) were performed. The study included 90 women with MTS and 20 women with pure Turner Syndrome (PTS) who underwent 140 and 25 oocyte donation (OD) cycles, respectively. INTERVENTION(S): In vitro fertilization for PGT-A (fluorescence in situ hybridization/arrays-next generation sequencing) or OD. MAIN OUTCOME MEASURE (S): Reproductive outcome and feto-maternal outcomes. RESULTS: The live birth rate (LBR) per embryo transfer in patients with MTS tended to be higher in OD 37.7% (95% confidence interval [CI]: 29.3-46.1) than that observed for PGT-A 22.5% (95% CI 7.8-38.2), and the cumulative LBR (CLBR), with 77.6% vs. 43.3%, respectively. Likewise, the LBR per patient was significant when comparing PGT-A vs. OD, with 12.5% (95 CI 3.9-21.1) vs. 51.1% (40.7-61.4), respectively. While focusing on the X chromosome, partial MTS (PTS), we found significant differences in the CLBR per embryo transfer, with 77.6% vs. 29.2%, and also in the LBR per patient: 51.1% (40.7-61.4) in MTS vs. 15% (95 CI 0.0-30.1) in PTS. CONCLUSION(S): Oocyte donation is the best reproductive option in females with Turner Syndrome with or without mosaicisms. Nevertheless, PGT-A is a valid therapeutic option in patients with MTS using their own oocytes, and OD should not necessarily be directly recommended.
引用
- Giles J, Meseguer M, Mercader A, et al. Preimplantation genetic testing for aneuploidy in patients with partial X monosomy using their own oocytes: is this a suitable indication? Fertil Steril. 2020. PMID: 32680612. doi:10.1016/j.fertnstert.2020.04.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。